Lineage Cell Therapeutics
LCTX
#8976
Rank
NZ$0.17 B
Marketcap
$0.77
Share price
3.62%
Change (1 day)
-67.66%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2024 (TTM): -NZ$35.91 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are NZ$9.49 Million. , an increase over its 2023 earnings that were of -NZ$44.2 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$38.38 Million-13.16%
2023 -NZ$44.2 Million9.83%
2022 -NZ$40.24 Million-54.24%
2021 -NZ$87.93 Million86.07%
2020 -NZ$47.26 Million-31.97%
2019 -NZ$69.46 Million-5.42%
2018 -NZ$73.44 Million1.1%
2017 -NZ$72.65 Million-31.06%
2016 -NZ$0.11 Billion-10.38%
2015 -NZ$0.12 Billion29.69%
2014 -NZ$90.66 Million31.68%
2013 -NZ$68.85 Million
2011 -NZ$33.42 Million89.78%
2010 -NZ$17.61 Million206.06%
2009 -NZ$5.76 Million-0.58%
2008 -NZ$5.79 Million164.89%
2007 -NZ$2.19 Million-30.22%
2006 -NZ$3.14 Million
2002 -NZ$3.64 Million-41.04%
2001 -NZ$6.17 Million-32.04%
2000 -NZ$9.08 Million-11.85%
1999 -NZ$10.3 Million
1997 -NZ$6.62 Million12.12%
1996 -NZ$5.9 Million106.25%
1995 -NZ$2.86 Million-11.11%
1994 -NZ$3.22 Million50%
1993 -NZ$2.15 Million20%
1992 -NZ$1.79 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.26 Billion 565.31%๐Ÿ‡บ๐Ÿ‡ธ USA